en

PRODUCT DETAIL

ELREXFIO 40 mg/ml injekčný roztok

Code 5229E
MA number EU/1/23/1770/001
Product Form: sol inj 1x1,1 ml/44 mg (liek.inj.skl.)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
MAH, country: Pfizer Europe MA EEIG, Belgium
Shelf life: 24
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 07.12.2023
Validity: 07.12.2024
SmPC + PL: European Medicines Agency's database
Dokument: Elrexfio_Karta pacienta.pdf  
Safety feature Yes
Data update: 05.01.2024
eu-flag.png sk-flag.png